Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew F Daley

Showing results (171-180 of 257) with videos related to

Pageof 26
Sort By:
Human Vaccines & Immunotherapeutics|December 28, 2022
Extended surveillance to assess safety of 9-valent human papillomavirus vaccineMaria E Sundaram, Burney A Kieke, Kayla E Hanson, et al.
Pediatrics|June 30, 2022
Safety of Live-Attenuated Vaccines in Children Exposed to Biologic Response Modifiers in UteroOusseny Zerbo, Sharareh Modaressi, Kristin Goddard, et al.
Journal of Public Health Management and Practice : JPHMP|August 27, 2021
A Governance Framework to Integrate Longitudinal Clinical and Community Data in a Distributed Data Network: The Childhood Obesity Data InitiativeEmily M Kraus, Kenneth A Scott, Rachel Zucker, et al.
Academic Pediatrics|April 29, 2014
School-located influenza vaccination with third-party billing: outcomes, cost, and reimbursementAllison Kempe, Matthew F Daley, Jennifer Pyrzanowski, et al.
Vaccine|May 21, 2011
Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenzaNatalie L McCarthy, Julianne Gee, Eric Weintraub, et al.
Archives of Pediatrics & Adolescent Medicine|August 4, 2011
Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalinkJason M Glanz, Sophia R Newcomer, Simon J Hambidge, et al.
American Journal of Epidemiology|January 8, 2013
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety studyJennifer C Nelson, Onchee Yu, Clara P Dominguez-Islas, et al.
Circulation. Cardiovascular Quality and Outcomes|August 28, 2014
Lipid screening in children and adolescents in community practice: 2007 to 2010Karen L Margolis, Louise C Greenspan, Nicole K Trower, et al.
International Journal of Medical Informatics|May 27, 2019
The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety DatalinkChengyi Zheng, Wei Yu, Fagen Xie, et al.
Pharmacoepidemiology and Drug Safety|November 18, 2017
The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink studyMatthew F Daley, Christina L Clarke, Jason M Glanz, et al.
Pageof 26

Showing results (171-180 of 257) with videos related to

Sort By:
Pageof 26
Human Vaccines & Immunotherapeutics|December 28, 2022
Extended surveillance to assess safety of 9-valent human papillomavirus vaccineMaria E Sundaram, Burney A Kieke, Kayla E Hanson, et al.
Pediatrics|June 30, 2022
Safety of Live-Attenuated Vaccines in Children Exposed to Biologic Response Modifiers in UteroOusseny Zerbo, Sharareh Modaressi, Kristin Goddard, et al.
Journal of Public Health Management and Practice : JPHMP|August 27, 2021
A Governance Framework to Integrate Longitudinal Clinical and Community Data in a Distributed Data Network: The Childhood Obesity Data InitiativeEmily M Kraus, Kenneth A Scott, Rachel Zucker, et al.
Academic Pediatrics|April 29, 2014
School-located influenza vaccination with third-party billing: outcomes, cost, and reimbursementAllison Kempe, Matthew F Daley, Jennifer Pyrzanowski, et al.
Vaccine|May 21, 2011
Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenzaNatalie L McCarthy, Julianne Gee, Eric Weintraub, et al.
Archives of Pediatrics & Adolescent Medicine|August 4, 2011
Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalinkJason M Glanz, Sophia R Newcomer, Simon J Hambidge, et al.
American Journal of Epidemiology|January 8, 2013
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety studyJennifer C Nelson, Onchee Yu, Clara P Dominguez-Islas, et al.
Circulation. Cardiovascular Quality and Outcomes|August 28, 2014
Lipid screening in children and adolescents in community practice: 2007 to 2010Karen L Margolis, Louise C Greenspan, Nicole K Trower, et al.
International Journal of Medical Informatics|May 27, 2019
The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety DatalinkChengyi Zheng, Wei Yu, Fagen Xie, et al.
Pharmacoepidemiology and Drug Safety|November 18, 2017
The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink studyMatthew F Daley, Christina L Clarke, Jason M Glanz, et al.
Pageof 26